Heat shock protein 70 (HSP70), an intracellular chaperone ''stress protein," has been identified in the extracellular milieu, where it may exert regulatory effects upon monocytes. HSPs are overexpressed in many cancers and implicated in tumorigenesis. Few studies have examined the relationship between psychosocial factors and HSP levels, particularly in cancer. The purpose of the present study was to examine the relationship between negative psychosocial states (life events stress and negative mood states) and serum concentration of HSP70 antibodies among women with endometrial cancer, the fourth most common cancer among women in the United States. Thirty-six women scheduled to undergo surgery for suspected endometrial adenocarcinoma underwent a psychosocial assessment and peripheral venous blood draw. Life events stress was assessed using an abbreviated version of the Life Experiences Survey; negative mood states were assessed using abbreviated versions of the Structured Interview Guide for the Hamilton Anxiety and Depression Scales and the Profile of Mood States. HSP70 antibody levels were regressed sequentially on life events stress and negative mood variables while controlling for body mass index (BMI) and cancer stage. Results revealed that greater HSP70 antibody concentrations were associated with greater impact of recent negative life events (p = .04), anxious symptomatology (p = .007), depressive symptomatology (p = .03), and total mood disturbance (p = .001) after controlling for BMI and cancer stage. While based on a modest sample size, these preliminary results suggest that largerscale research exploring the relationships among psychosocial factors and HSP70 in cancer patients may be warranted.
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Introduction
Molecular chaperones are a family of cellular proteins that assist polypeptides with correct assembly and disassembly. There are several classes of molecular chaperones, including chaperonins and heat shock proteins (HSPs). HSPs have both intracellular and extracellular functions. Intracellularly, HSPs chaperone misfolded proteins and protect cells from stressful environmental and physiological stimuli, while extracellularly, HSPs act as cytokines by modulating immunity (Asea et al., 2000) .
HSPs have been implicated in tumorigenesis (Ciocca and Calderwood, 2005) . HSP70, one of the most thoroughly studied small (70 kDa) chaperone proteins, is overexpressed in many cancers, including endometrial cancer. Endometrial cancer is the fourth most prevalent cancer and the eighth leading cause of cancer-related death among US women (American Cancer Society, 2007) . In endometrial cancer, HSP70 overexpression is associated with p53 tumor suppressor gene mutation/overexpression, poorly differentiated tumor grade, more aggressive variants, more advanced tumor stages, estrogen and progesterone receptor (ER/PR) negative tumors, and poorer survival rates (Nanbu et al., 1996 (Nanbu et al., , 1998 .
HSP70 overexpression may contribute to endometrial cancer progression in several ways. Although HSP70 overexpression protects cells from proteotoxic damage, it also inhibits apoptosis, allowing tumor cells to escape immune surveillance and develop chemotherapy resistance (Morano, 2007) . In the extracellular milieu, exogenous HSP70 has been found to bind to human monocytes, where it can activate nuclear factor (NF)-jB and upregulate proinflammatory cytokine expression (Asea et al., 2000) implicated in endometrial cancer progression (Bellone et al., 2005; Chopra et al., 1997) .
